Address	Joukahaisenkatu 6 Turku FP 20520 Finland
Employees	-
Website	http://www.faron.com
Updated	07/08/2019
Faron Pharmaceuticals Oy engages in the provision of biopharmaceutical development. The company focuses on novel treatments for medical conditions such as acute organ traumas, cancer immunotherapy and vascular damage. It operates through the Traumakine and Clevegen brands for acute respiratory distress syndrome, and for pre-clinical anti-Clever-1 antibody respectively.